Potassium Channel Tetramerisation Domain Containing 12 (KCTD12) (Middle Region) Peptide
KCTD12
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all KCTD12 products
- KCTD12 (Potassium Channel Tetramerisation Domain Containing 12 (KCTD12))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- AQADAKFRRV ARITVCGKTS LAKEVFGDTL NESRDPDRPP ERYTSRYYLK
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- KCTD12 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- KCTD12 (Potassium Channel Tetramerisation Domain Containing 12 (KCTD12))
- Synonyms
- AU046135 Peptide, AW538430 Peptide, Pfet1 Peptide, Pfetin Peptide, C13orf2 Peptide, PFET1 Peptide, PFETIN Peptide, potassium channel tetramerisation domain containing 12 Peptide, potassium channel tetramerization domain containing 12 Peptide, Kctd12 Peptide, KCTD12 Peptide
- Background
-
Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization.
Alias Symbols: PFET1, PFETIN, C13orf2
Protein Size: 325 - Gene ID
- 115207
- NCBI Accession
- NM_138444, NP_612453
- UniProt
- Q96CX2
-
You are here:
